Navin Viswakarma

6PUBLICATIONS
12CO-AUTHORS
Molecular targetsPredictive and prognostic markersNonlinear optics and spectroscopy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 12, 2022
Mixed lineage kinase 3 and CD70 cooperation sensitize trastuzumab-resistant HER2+ breast cancer by ceramide-loaded nanoparticles.

Sandeep Kumar, Subhasis Das, Jingjing Sun

|Jul 05, 2022
Ets1 mediates sorafenib resistance by regulating mitochondrial ROS pathway in hepatocellular carcinoma.

Kanchan Vishnoi, Rong Ke, Navin Viswakarma

|May 05, 2022
In Vivo Partial Oxygen Pressure Assessment in Subcutaneous and Intraperitoneal Sites Using Imaging of Solid Oxygen Probe.

Navin Viswakarma, Eliyas Siddiqui, Sonny Patel

|Sep 13, 2021
MAP4K4 promotes pancreatic tumorigenesis via phosphorylation and activation of mixed lineage kinase 3.

Sunil Kumar Singh, Sandeep Kumar, Navin Viswakarma

|Aug 23, 2020
Transcription Factors in Cancer Development and Therapy.

Kanchan Vishnoi, Navin Viswakarma, Ajay Rana

|Jan 16, 2020
Mitogen-Activated Protein Kinase Inhibitors and T-Cell-Dependent Immunotherapy in Cancer.

Sandeep Kumar, Daniel R Principe, Sunil Kumar Singh

Pageof 1